Compared to mice having undergone tMCAO and received vehicle treatment, mice having received PNU post-stroke did not show a change (count or percentage) of inflammatory Th17 (CD4+IL17+) cells in the draining lymph nodes (Figure 4B) or spleen (Figure 5B). This evidence concerns the gene IL17A and stroke disorder.